Brucea javanica oil emulsion improves the effect of radiotherapy on esophageal cancer cells by inhibiting cyclin D1-CDK4/6 axis

doi:10.3748/wjg.v25.i20.2463

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 25, Issue 20

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6655)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-4) series.

Item

Count

PDF

365

WORD

239

HTML

3674

Figures (1-4)

241

Sum=4519

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

795

Download

1341

Sum=2136

May 28, 2019 (publication date) through May 1, 2024

Times Cited of This Article

Times Cited (12)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Gastroenterol. May 28, 2019; 25(20): 2463-2472
Published online May 28, 2019. doi: 10.3748/wjg.v25.i20.2463

Full Size Figure Download Figure

Figure 2 The migration and invasion of esophageal carcinoma cells treated with Brucea javanica oil emulsion. Wound healing assays (A) and transwell invasion assays (B) were used in 8 μg/mL of Brucea javanica oil emulsion. At least three repeats were carried out, and the mean ± SD was presented, ^aP < 0.05; ^bP < 0.01. BJOE: Brucea javanica oil emulsion; SD: Standard deviation.

Citation: Qiu ZH, Zhang WW, Zhang HH, Jiao GH. Brucea javanica oil emulsion improves the effect of radiotherapy on esophageal cancer cells by inhibiting cyclin D1-CDK4/6 axis. World J Gastroenterol 2019; 25(20): 2463-2472
URL: https://www.wjgnet.com/1007-9327/full/v25/i20/2463.htm
DOI: https://dx.doi.org/10.3748/wjg.v25.i20.2463